Gongwin Biopharm Holdings Co., Ltd.
6617
Rank in Stocks
#12843
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Share Price
$3.60
Last synced: 2026-11-10
Market Cap
$435.69M
Change (1 day)
9.26%
Change (1 year)
29.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Gongwin Biopharm Holdings Co., Ltd. (6617)
Category
Healthcare
Operating Margin for Gongwin Biopharm Holdings Co., Ltd. (6617)
Operating Margin as of November 2026 TTM: -573.78%
According to Gongwin Biopharm Holdings Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -573.78%. At the end of 2025 the company had an operating margin of -568.76%.
Operating Margin history for Gongwin Biopharm Holdings Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -573.78% | 0.88% |
| 2025 | -568.76% | 12.45% |
| 2024 | -505.80% | -28.24% |
| 2023 | -704.87% | -97.21% |
| 2022 | -25,279.79% | 154.49% |
| 2021 | -9,933.51% | -16.26% |
| 2020 | -11,862.79% | -77.16% |
| 2019 | -51,944.76% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -100.00% |
US
|
|
| 1.30% | -100.00% |
US
|
|
| 1.03% | -100.00% |
US
|
|
| 0.91% | -100.00% |
US
|
|
| 9.21% | -100.02% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Gongwin Biopharm Holdings Co., Ltd.'s operating margin
What is Gongwin Biopharm Holdings Co., Ltd.'s operating margin?
Gongwin Biopharm Holdings Co., Ltd.'s operating margin is -573.78%, as of Nov 2026.
What was Gongwin Biopharm Holdings Co., Ltd.'s operating margin in 2025?
In 2025, Gongwin Biopharm Holdings Co., Ltd.'s operating margin was -568.76%, compared with -505.80% in 2024.
How has Gongwin Biopharm Holdings Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Gongwin Biopharm Holdings Co., Ltd.'s operating margin was highest in 2024 (-505.80%) and lowest in 2022 (-25,279.79%).
How does Gongwin Biopharm Holdings Co., Ltd.'s operating margin compare with similar companies?
Gongwin Biopharm Holdings Co., Ltd.'s operating margin (-573.78%) is lower than that of all 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.